Publisher
Springer Berlin Heidelberg
Reference75 articles.
1. Yates J, Glidewell 0, Wiernik PH, Cooper MR, Steinber D, Dosik H, Levy R, Hoagland C, Henry P, Gottlieb H, Cornell C, Berenberg J, Hutchinson JH, Raich P, Nissen N, Ellison RR, Frelick R, James GN, Falkson G, Silver RT, Haurani F, Green M, Henderson E, Leone L, Holland JF: Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: CALGB study. Blood 60: 2, 454–462, 1982.
2. Priesler H, Davis RB, Kirschner J, Dupre E, Richards F, Hoagland HC, Kopel S, Levy RN, Carey R, Shulman P, Gottlieb AJ, Mclntyre OR: Comparison of three remission induction regimens and two post induction strategies for the treatment of acute non-lymphocyte leukemia: CALGB study. Blood 69: 5, 1441–1449, 1987.
3. Bishop JF, Lowenthal RM, Joshua D, Matthews JP, Todd D, Cobcroft R, Whiteside MG, Kronenberg H, Ma D, Dodds A, Herrman R, Szer J, Wolf MM, Young G. Etoposide in acute non-lymphocytic leukemia. Blood 75, 27–32, 1990.
4. Bishop JF, McGrath K, Wolf MM, Matthews JP, De Luise T, Holdsworth R, Yuen K, Veal M, Whiteside MG/M2, Cooper IA, Szer J. Clinical factors influencing the efficacy of pooled platelet transfusions. Blood 71: 383–387, 1988.
5. Bishop JF, Matthews JP, McGrath K, Wolf MM, Yuen K. Factors influencing 20 hour increment following platelet transfusions. Transfusion 31: 392–396,1991.